Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

<ul><li>Lantheus is a leader in radiopharmaceutical offerings in oncology & precision diagnostics.</li><li>It offers a portfolio of diagnostic & therapeutic products directly & via partnerships & licensing.</li><li>The primary revenue driver is Pylarify, a PET tracer for PSMA-expressing prostate cancer.</li></ul>

Lantheus is a leader in radiopharmaceutical offerings in oncology & precision diagnostics.It offers a portfolio of diagnostic & therapeutic products directly & via partnerships & licensing.The primary revenue driver is Pylarify, a PET tracer for PSMA-expressing prostate cancer.

LNTH: Competition Escalates in PSMA Imaging

Lantheus Holdings

LNTH: Competition Escalates in PSMA Imaging